Clinical trial
Open-labeled, Non-randomized, Self-controlled Study to Evaluate the Safety and Performance of EZVent in Hospitalized Mechanically Ventilated Patients
NCT05399017 is registered in ClinicalTrials.gov with Triclinium Clinical Development Middle East and North Africa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-labeled, Non-randomized, Self-controlled Study to Evaluate the Safety and Performance of EZVent in Hospitalized Mechanically Ventilated Patients
- Lead sponsor
- Triclinium Clinical Development Middle East and North Africa
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2022
- Completion date
- August 30, 2022
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory disease, respiratory failure